RM

Rekha Mahesh Sarvaiya

Director Director DIN 09576621
DIN 09576621 First appointment Apr 2022 Primary industry Environment
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2022
Shareholding value •••• Premium profile

About Rekha Mahesh Sarvaiya

Data last updated:

Rekha Mahesh Sarvaiya was a Director at En-Cler Biomedical Waste Management Private Limited (2022–2025) and Director at En-Cler Biomedical Waste Private Limited (2022–2025). The companies operate in Environment.

DIN 09576621
Primary Designation Director
Industry Environment
First Appointment 20 Apr 2022

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Apr 20222019Active
Director20 Apr 20222012₹21.88 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
En-Cler Biomedical Waste Management Private Limited
En-Cler Biomedical Waste Private Limited
Premium access

Shareholding and investment profile for Rekha Mahesh Sarvaiya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Mahesh Sarvaiya

Rekha Mahesh Sarvaiya was first appointed on 20 Apr 2022 as Director at En-Cler Biomedical Waste Management Private Limited.

Rekha Mahesh Sarvaiya held 2 earlier board appointments: En-Cler Biomedical Waste Management Private Limited (Director, 20 Apr 2022 to 23 Jan 2025); En-Cler Biomedical Waste Private Limited (Director, 20 Apr 2022 to 23 Jan 2025).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available